Cargando…

Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation

Insomnia, whether chronic or intermittent, is a common central nervous system disease. Ciwujia Tablet (CWT) is a well-known traditional Chinese medicine (TCM) made from the extract of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. This medication is commonly used for treating insomnia in Chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hongda, Yang, Le, Wan, Chunlei, Li, Zhineng, Yan, Guangli, Han, Ying, Sun, Hui, Wang, Xijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468710/
https://www.ncbi.nlm.nih.gov/pubmed/36110515
http://dx.doi.org/10.3389/fphar.2022.990996
_version_ 1784788475579465728
author Liu, Hongda
Yang, Le
Wan, Chunlei
Li, Zhineng
Yan, Guangli
Han, Ying
Sun, Hui
Wang, Xijun
author_facet Liu, Hongda
Yang, Le
Wan, Chunlei
Li, Zhineng
Yan, Guangli
Han, Ying
Sun, Hui
Wang, Xijun
author_sort Liu, Hongda
collection PubMed
description Insomnia, whether chronic or intermittent, is a common central nervous system disease. Ciwujia Tablet (CWT) is a well-known traditional Chinese medicine (TCM) made from the extract of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. This medication is commonly used for treating insomnia in China, but the lack of in-depth research focused on the chemical ingredients of CWT creates a gap in knowledge regarding its effective constituents against insomnia. Considering that the therapeutic material basis, targets, and pathways related to this drug have not been fully investigated by scholars in the field, the focus of this study is on identifying the chemical ingredients or structural characteristics of CWT by the UPLC-Q-TOF-MS/MS technique. Besides, concepts of network pharmacology were also used to investigate the targets and pathways of CWT. An insomnia rat model was established by intraperitoneal injection of p-chlorophenylalanine, and the results were verified through various experiments. A total of 46 ingredients were identified in CWT, such as eleutheroside B, eleutheroside E, isofraxidin, and chlorogenic acid. Among them, 17 ingredients with good solubility, favorable gastrointestinal absorption, and high bioavailability were selected for network pharmacological analysis. It was concluded that CWT participated in the regulation of neurotransmitter levels, modulation of ion transport, neurotransmitter receptor activity, synaptic transmission, dopaminergic transmission and other essential processes. Results from the animal experiments showed that CWT can increase the content of inhibitory neurotransmitters 5-HT and GABA in the brain, reduce the synthesis of excitatory escalating transmitters DA and NE, shorten the sleep latency and prolong the sleep duration of insomnia rats. Furthermore, CWT could significantly alleviate the symptoms of insomnia in model rats. Identifying the chemical ingredients of CWT in this experiment is of great significance for exploring its potential curative effects, which provides a solid basis for further understanding the therapeutic value of this medication.
format Online
Article
Text
id pubmed-9468710
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94687102022-09-14 Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation Liu, Hongda Yang, Le Wan, Chunlei Li, Zhineng Yan, Guangli Han, Ying Sun, Hui Wang, Xijun Front Pharmacol Pharmacology Insomnia, whether chronic or intermittent, is a common central nervous system disease. Ciwujia Tablet (CWT) is a well-known traditional Chinese medicine (TCM) made from the extract of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. This medication is commonly used for treating insomnia in China, but the lack of in-depth research focused on the chemical ingredients of CWT creates a gap in knowledge regarding its effective constituents against insomnia. Considering that the therapeutic material basis, targets, and pathways related to this drug have not been fully investigated by scholars in the field, the focus of this study is on identifying the chemical ingredients or structural characteristics of CWT by the UPLC-Q-TOF-MS/MS technique. Besides, concepts of network pharmacology were also used to investigate the targets and pathways of CWT. An insomnia rat model was established by intraperitoneal injection of p-chlorophenylalanine, and the results were verified through various experiments. A total of 46 ingredients were identified in CWT, such as eleutheroside B, eleutheroside E, isofraxidin, and chlorogenic acid. Among them, 17 ingredients with good solubility, favorable gastrointestinal absorption, and high bioavailability were selected for network pharmacological analysis. It was concluded that CWT participated in the regulation of neurotransmitter levels, modulation of ion transport, neurotransmitter receptor activity, synaptic transmission, dopaminergic transmission and other essential processes. Results from the animal experiments showed that CWT can increase the content of inhibitory neurotransmitters 5-HT and GABA in the brain, reduce the synthesis of excitatory escalating transmitters DA and NE, shorten the sleep latency and prolong the sleep duration of insomnia rats. Furthermore, CWT could significantly alleviate the symptoms of insomnia in model rats. Identifying the chemical ingredients of CWT in this experiment is of great significance for exploring its potential curative effects, which provides a solid basis for further understanding the therapeutic value of this medication. Frontiers Media S.A. 2022-08-30 /pmc/articles/PMC9468710/ /pubmed/36110515 http://dx.doi.org/10.3389/fphar.2022.990996 Text en Copyright © 2022 Liu, Yang, Wan, Li, Yan, Han, Sun and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Hongda
Yang, Le
Wan, Chunlei
Li, Zhineng
Yan, Guangli
Han, Ying
Sun, Hui
Wang, Xijun
Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation
title Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation
title_full Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation
title_fullStr Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation
title_full_unstemmed Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation
title_short Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation
title_sort exploring potential mechanism of ciwujia tablets for insomnia by uplc-q-tof-ms/ms, network pharmacology, and experimental validation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468710/
https://www.ncbi.nlm.nih.gov/pubmed/36110515
http://dx.doi.org/10.3389/fphar.2022.990996
work_keys_str_mv AT liuhongda exploringpotentialmechanismofciwujiatabletsforinsomniabyuplcqtofmsmsnetworkpharmacologyandexperimentalvalidation
AT yangle exploringpotentialmechanismofciwujiatabletsforinsomniabyuplcqtofmsmsnetworkpharmacologyandexperimentalvalidation
AT wanchunlei exploringpotentialmechanismofciwujiatabletsforinsomniabyuplcqtofmsmsnetworkpharmacologyandexperimentalvalidation
AT lizhineng exploringpotentialmechanismofciwujiatabletsforinsomniabyuplcqtofmsmsnetworkpharmacologyandexperimentalvalidation
AT yanguangli exploringpotentialmechanismofciwujiatabletsforinsomniabyuplcqtofmsmsnetworkpharmacologyandexperimentalvalidation
AT hanying exploringpotentialmechanismofciwujiatabletsforinsomniabyuplcqtofmsmsnetworkpharmacologyandexperimentalvalidation
AT sunhui exploringpotentialmechanismofciwujiatabletsforinsomniabyuplcqtofmsmsnetworkpharmacologyandexperimentalvalidation
AT wangxijun exploringpotentialmechanismofciwujiatabletsforinsomniabyuplcqtofmsmsnetworkpharmacologyandexperimentalvalidation